BioCentury
ARTICLE | Clinical News

Aspirin-PC: Phase II data

May 3, 2010 7:00 AM UTC

In a U.S. Phase II trial in 201 healthy adults ages 50-75, daily PL2200 for 7 days significantly reduced the incidence of gastric and duodenal ulcers by 71% (p=0.0069) and the incidence of combined er...